Viewing Study NCT01144351


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:33 PM
Study NCT ID: NCT01144351
Status: TERMINATED
Last Update Posted: 2015-12-14
First Post: 2010-06-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
Sponsor: Elan Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module